AnalystsCharles Robertson IICharles Robertson II's Stock Forecasts
AnalystsCharles Robertson II
Sectors:
Industries:
Analyst Ranking
Top 30%
#1441 out of 4872 analysts
Average Return
+33.45%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
Charles Robertson II's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Chinook Therapeutics IncKDNY | +103.54% | $18.66 | $37.98 | 2023-05-02 - 2023-06-12 | Strong Buy |
Wpx Energy IncWPX | +96.82% | $9.13 | $17.97 | 2017-06-22 - 2018-06-22 | Buy |
Chinook Therapeutics IncKDNY | +76.57% | $21.51 | $37.98 | 2023-05-17 - 2023-06-12 | Strong Buy |
Fennec Pharmaceuticals IncFENC | +25.91% | $8.49 | $10.69 | 2023-04-06 - 2024-04-05 | Strong Buy |
ConocophillipsCOP | +1.13% | $51.38 | $51.96 | 2016-12-12 - 2017-12-12 | Buy |
Charles Robertson II Analyst Color
Get additional color on Charles Robertson II's coverage of popular stocks
Charles Robertson II's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Wpx Energy IncWPX | 2 | Buy | $19.00 | N/A | Initiates Coverage On | 6 years ago |
Southwestern Energy CoSWN | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
ConocophillipsCOP | 1 | Buy | $59.00 | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.